GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gensight Biologics SA (LTS:0RIM) » Definitions » Float Percentage Of Total Shares Outstanding

Gensight Biologics (LTS:0RIM) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 15, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Gensight Biologics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Gensight Biologics's float shares is 0.00 Mil. Gensight Biologics's total shares outstanding is 130.11 Mil. Gensight Biologics's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Gensight Biologics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Gensight Biologics's Institutional Ownership is 0.66%.

Gensight Biologics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Gensight Biologics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/130.11
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gensight Biologics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gensight Biologics SA (LTS:0RIM) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XPAR:ALGAE XPAR:ABNX XPAR:ALGEN XPAR:POXEL XPAR:ALDVI XPAR:AELIS XPAR:ALCOX XPAR:ALVAL XPAR:ALNFL XPAR:ALPAT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
SIGHT:France
Address
74, rue du Faubourg Saint-Antoine, Paris, FRA, 75012
Website
https://www.gensight-biologics.com
Gensight Biologics SA is a clinical-stage biotechnology group discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. The company's pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence and Optogenetics, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. The group's focus is on ophthalmology, where it develops product candidates to restore eyesight to patients suffering from retinal diseases. The product candidate, LUMEVOQ, was developed using the MTS technology platform and is designed to treat LHON by restoring the function of retinal diseases resulting from mutations.

Gensight Biologics Headlines

No Headlines